Cargando…
Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer
Aminoacyl-tRNA synthetase-interacting multi-functional protein 2 (AIMP2) works as potent tumor suppressor, while its splicing variant lacking exon 2 (AIMP2-DX2) competes with AIMP2 for binding to target proteins and compromises its anti-tumor activity. Assuming that AIMP2 and its variant AIMP2-DX2 c...
Autores principales: | Jung, Ji Ye, Kim, Eun Young, Kim, Arum, Chang, Joon, Kwon, Nam Hoon, Moon, Youngji, Kang, Eun Joo, Sung, Jun Sik, Shim, Hyunbo, Kim, Sunghoon, Chang, Yoon Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479239/ https://www.ncbi.nlm.nih.gov/pubmed/28638448 http://dx.doi.org/10.7150/jca.18450 |
Ejemplares similares
-
An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody
por: Kim, Dae Gyu, et al.
Publicado: (2020) -
Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis
por: Choi, Jin Woo, et al.
Publicado: (2011) -
VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2
por: Yun, Seung Pil, et al.
Publicado: (2017) -
Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer
por: Ku, Jayoung, et al.
Publicado: (2020) -
AIMP3 Deletion Induces Acute Radiation Syndrome-like Phenotype in Mice
por: Kim, Doyeun, et al.
Publicado: (2018)